Internet Explorer is no longer supported by Microsoft. To browse the NIHR site please use a modern, secure browser like Google Chrome, Mozilla Firefox, or Microsoft Edge.

23/52 Body fluid-based biomarkers in traumatic brain injury


23 March 2023


13:00 on 22 August 2023


Supporting Information

Please note that the Word version of the Stage 1 application form is to be used as a guide and to assist with completion of the online application form only, for example to see how many characters are accepted in each section and how the printed complete form is laid out. Please do not try to use this as an application form, you must apply using the online form available through the links available when calls are open. You should also refer to the application form guidance notes.

The following guide compares the remits of NIHR and MRC translational research programmes to help researchers to determine which funding scheme is the most appropriate for their proposed project:

The Efficacy and Mechanism Evaluation (EME) Programme and Health Technology Assessment (HTA) Programme are accepting Stage 1 applications to this cross programme call.

In order to apply you will need to carefully review the:

For further details on aspects such as eligibility, collaboration and team expertise, timescales and funding limits as well as other guidance on applying please review the Supporting information document linked above alongside the Stage 1 guidance notes.

All primary research projects are expected to establish a programme appointed Study Steering Committee and it is important that you read the Research Governance Guidance before completing your application. Costs incurred by this committee should be included in the budget as appropriate.